Xi Chen

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Systematic Review

Transforming Growth Factor

Glycemic Control

Top Venues

Journal of natural products

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Xi Chen, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, Zhijie Xu
Tabersonine Enhances Olaparib Sensitivity through FHL1-Mediated Epithelial-Mesenchymal Transition in an Ovarian Tumor. Journal of natural products 87 (4) (2024)
Xi Chen, Yuanliang Yan, Wang-Rui Liu, Yuanhong Liu, Abhimanyu Thakur, Qiuju Liang, Zhijie Xu
Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer. Clinical and translational medicine 13 (7) (2023)